The advent of novel biologics for the therapy of inflammatory bowel disease (IBD) has substantially increased the ability to induce and maintain remission of patients. With clinical response and ...

The introduction of biologic therapy for the treatment of IBD has substantially changed its management. The safety concerns associated with biologic therapies include the increased risk of ...

Read More: The Connection Between IBD and Aging Infusions of biologics have been a mainstay of treatment for moderate and severe IBD for the past 20 years. But a lot has changed during those two ...

Economic analyses conducted in the era pre-biologic therapy mostly centered upon the estimation or calculation of the direct costs of IBD treatment. Some rough extrapolations of the indirect costs ...

Technological innovations and advancements in research and development (R&D) are significantly influencing the future of the global inflammatory bowel disease treatment market. Biologic therapies ...

Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment ...

The introduction of biologics has changed treatment for many people with ulcerative colitis. Here’s what you need to know about the risks and benefits. Over the past 15 years, treatment options ...

Biologic medical therapies, or biologics, are an important type of treatment for Crohn’s disease and inflammatory bowel disease. Biologics are a wide-ranging class of drugs, and there are many ...

Background: The advent of biologic agents for the treatment of inflammatory bowel disease (IBD) was accompanied in parallel with emerging understanding of persisting underlying inflammation and ...

This market is benefiting from a growing understanding of IBD, as well as the development of new and more effective drug classes, including biologics, anti-integrins, and TNF inhibitors. These ...